Texas A&M University School of Law is launching a new blog and associated website www.TradeRxReport.com, which explores questions of access to affordable medicines and health care that arise at the intersection of intellectual property law and international trade. With the increasing impact of the Coronavirus on the global economy and our healthcare systems, the importance of issues around the affordability of pharmaceuticals, access to healthcare and medication and globalization become more apparent each day. The inter-relationship of health, trade and intellectual property has been a “hot topic” since the 1980s, when the World Trade Organization was established and the TRIPS Agreement on intellectual property rights was enacted. The current global pandemic merely underscores the need to find a workable solution to the challenge of ensuring innovation and access to medicines on a global scale – and the value of a forum focused on that topic.
Earlier this spring, the Center for Law and Intellectual Property at Texas A&M University School of Law devoted its annual symposium to commemorating the silver anniversary of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) of the World Trade Organization (WTO).